Favorable outcomes with tacrolimus in two patients with refractory interstitial lung disease associated with polymyositis/dermatomyositis

Clinical and Experimental Rheumatology

Volumn 23, Issue 5, 2005, Pages 707-710

  Ochi, Sae ^a   Nanki, Toshihiro ^a   Takada, Kazuki ^a   Suzuki, Fumihito ^a   Komano, Yukiko ^a   Kubota, Tetsuo ^a   Miyasaka, Nobuyuki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Dermatomyositis; Interstitial lung disease; Polymyositis; Tacrolimus

Indexed keywords

BAKTAR; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYCLOSPORIN A; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISOLONE; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; AGED; ANAMNESIS; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DERMATOMYOSITIS; DISEASE ASSOCIATION; DISEASE RESISTANCE; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; PATIENT REFERRAL; PHYSICAL EXAMINATION; POLYMYOSITIS; PRIORITY JOURNAL; REMISSION; TREATMENT OUTCOME;

AGED; DERMATOMYOSITIS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED; TACROLIMUS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 24944532241     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. SCHWARZ MI, MATTHAY RA, SAHN SA, STANFORD RE, MARMORSTEIN BL, SCHEINHORN DJ: Interstitial lung disease in polymyositis and dermatomyositis: analysis of six cases and review of the literature. Medicine (Baltimore) 1976; 55: 89-104.
2. DICKEY BF, MYERS AR: Pulmonary disease in polymyositis/dermatomyositis. Semin Arthritis Rheum 1984; 14: 60-76.
3. YOSHIDA T, KOGA H, SAITOH F et al.: Pulse intravenous cyclophosphamide treatment for steroid-resistant interstitial pneumonitis associated with polymyositis. Intern Med 1999; 38: 733-8.
4. MAEDA K, KIMURA R, KOMUTA K, IGARASHI T: Cyclosporine treatment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis? Scand J Rheumatol 1997; 26: 24-9.
5. NAWATA Y, KURASAWA K, TAKABAYASHI K et al.: Corticosteroid resistant interstitial pneumonitis in dermatomyositis/polymyositis: prediction and treatment with cyclosporine. J Rheumatol 1999; 26: 1527-33.
6. NAGASAKA K, HARIGAI M, TATEISHI M et al.: Efficacy of combination treatment with cyclosporin A and corticosteroids for acute interstitial pneumonitis associated with dermatomyositis. Mod Rheumatol 2003; 13: 231-8.
7. DUMONT FJ: FK506, an immunosuppressant targeting calcineurin function. Curr Med Chem 2000; 7: 731-48.
8. WAKATA N, SAITO T, TANAKA S, HIRANO T, OKA K: Tacrolimus hydrate (FK506): therapeutic effects and selection of responders in the treatment of myasthenia gravis. Clin Neurol Neurosurg 2003; 106: 5-8.
9. YOCUM DE, FURST DE, KAINE JL et al.: Efficacy and safety of tacrolimus in patients with rheumatoid arthritis: a double-blind trial. Arthritis Rheum 2003; 48: 3328-37.
10. BANDOH S, FUJITA J, OHTSUKI Y et al.: Sequential changes of KL-6 in sera of patients with interstitial pneumonia associated with polymyositis/dermatomyositis. Ann Rheum Dis 2000; 59: 257-62.
11. MARIE I, HACHULLA E, CHERIN P et al.: Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 2002; 47: 614-22.
12. DOUGLAS WW, TAZELAAR HD, HARTMAN TE et al.: Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 2001; 164: 1182-5.
13. AUSTIN HA, III, KLIPPEL JH, BALOW JE et al.: Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 1986; 314: 614-9.
14. SHINOHARA T, HIDAKA T, MATSUKI Y et al.: Rapidly progressive interstitial lung disease associated with dermatomyositis responding to intravenous cyclophosphamide pulse therapy. Intern Med 1997; 36: 519-23.
15. SCHNABEL A, REUTER M, GROSS WL: Intravenous pulse cyclophosphamide in the treatment of interstitial lung disease due to collagen vascular diseases. Arthritis Rheum 1998; 41: 1215-20.
16. KURASAWA K, NAWATA Y, TAKABAYASHI K et al.: Activation of pulmonary T cells in corticosteroid-resistant and -sensitive interstitial pneumonitis in dermatomyositis/polymyositis. Clin Exp Immunol 2002; 129: 541-8.
17. ODDIS CV, SCIURBA FC, ELMAGD KA, STARZL TE: Tacrolimus in refractory polymyositis with interstitial lung disease. Lancet 1999; 353: 1762-3.
18. WILKES M, SEREIKA S, FERTIG N, LUCAS M, PEREZ A, ODDIS C: Treatment of antisynthetase associated interstitial lung disease with tacrolimus in patients with idiopathic inflammatory myopathy. Arthritis Rheum 2003; 48 (Suppl. 9): S434.
19. OCHIAI T, NAKAJIMA K, SAKAMOTO K et al.: Comparative studies on the immunosuppressive activity of FK506, 15-deoxyspergualin, and cyclosporine. Transplant Proc 1989; 21: 829-32.